Skip to main content
. 2019 Mar 14;11:2129–2138. doi: 10.2147/CMAR.S184922

Table 4.

Univariable and multivariable analyses of covariables associated with intracranial progression-free survival

Characteristics n Univariate Multivariate

HR (95% CI) P-value HR (95% CI) P-value

Number of brain metastasis
 >3 70 1.533 (0.969–2.427) 0.068 1.785 (1.110–2.871) 0.017
 ≤3 34
Therapy method
 EGFR-TKI + WBRT 56 0.590 (0.385–0.903) 0.015 0.504 (0.336–0.807) 0.004
 EGFR-TKI 48

Abbreviations: TKI, tyrosine kinase inhibitor; WBRT, whole-brain radiotherapy.